Almirall SA
F:E2Z
Relative Value
The Relative Value of one
E2Z
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 12.86 EUR,
Almirall SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
E2Z Competitors Multiples
Almirall SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Almirall SA
F:E2Z
|
2.8B EUR | 2.5 | 59.8 | 12.2 | 37.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
966.3B USD | 14.8 | 46.8 | 31.6 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.7B CHF | 4.8 | 31.2 | 13.1 | 15.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
249.4B CHF | 5.7 | 22.9 | 14.1 | 18.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.4B GBP | 5.5 | 31.3 | 17.3 | 24.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.1B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123B USD | 2.6 | 17.4 | 7.3 | 9 |